Introduction of BORTEZEST 2MG INJECTION:

Bortezest
2mg Injection is a chemotherapy medication that belongs to the class of
medicines called proteasome inhibitors. It consists of the active ingredient
Bortezomib. It is indicated for the treatment of multiple myeloma and mantle
cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma
cells that are predominant in the bone marrow. Mantle cell lymphoma is a less
common cancer affecting the lymph nodes. This medication is concomitantly used
with other chemotherapy medicines like pegylated liposomal doxorubicin,
rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or
thalidomide for patients who have not started treatment and are ineligible for
blood stem cell transplant.

The common side effects likely associated with Bortezest 2mg
Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning
sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation,
muscle and bone pain, hair loss, fever, infections, itching, redness,
dehydration, stomach problems, etc., Inform your physician if these side
effects disturb or persist in you.

Uses of BORTEZEST
2MG INJECTION:

• Treatment of multiple myeloma and mantle cell lymphoma.

How to use BORTEZEST 2MG INJECTION:

Your dose and frequency of administration will be decided by
your physician based on your disease condition and other factors. It will be
given to you by a healthcare professional. Do not self-administer.